Futures & Derivatives and Trading
Our Futures & Derivatives and Trading Group advises physical and financial market participants on the full range of legal, compliance and regulatory issues in structuring, offering and trading financial instruments, including derivatives, commodities and related products, such as repo and securities lending. Based in the U.S.-and U.K., we provide integrated litigation, enforcement, transactional and regulatory advice with a truly global reach.
Derivatives and Structured Products
The Legal 500 U.K. Solicitors (2025, 2026)
Derivatives (USA Nationwide)
Chambers USA (2026)
Ligand Pharmaceuticals, a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines, in connection with its private placement of $700 million aggregate principal amount of 0.0% convertible senior notes due 2031.
BofA Securities as underwriter for American Healthcare REIT’s more than $800 million public offering of 16.1 million shares of its common stock on a forward basis, including the option to purchase additional shares, which was exercised in full.